About lab
This is a model developed to predict concentrations of cergutuzumab amunaleukin (CEA-IL2v) after various systemic dosing intensities. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packageribba2018-mathematical-model-of-tumor-uptake-for-immunocytokine
Created2026-05-16
Updated2026-05-16
biomodels_ebicurateddrug-responsefaithfulimmunologyimmunotherapymicroenvironmentoncologypharmacologyphysiologysbmlsystemsbiologytumor-growthvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "epsilon_source_parameter",
"label": "Epsilon source parameter",
"units": "native SBML value",
"default": 0.25,
"maps_to": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.epsilon_source_parameter",
"description": "Epsilon source parameter. Maps to bundled SBML parameter `epsilon`."
},
{
"name": "initial_for_epsilon_source_parameter",
"label": "for epsilon source parameter",
"units": "native SBML value",
"default": 0.25,
"maps_to": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.initial_for_epsilon_source_parameter",
"description": "Initial for epsilon source parameter. Maps to bundled SBML parameter `ModelValue_2`."
},
{
"name": "initial_a_1_b",
"label": "A 1 b",
"units": "native SBML value",
"default": 8,
"maps_to": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.initial_a_1_b",
"description": "Initial A 1 b. Sets the initial value of bundled SBML symbol `A_1_b`."
},
{
"name": "initial_c_4_t",
"label": "C 4 T",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.initial_c_4_t",
"description": "Initial C 4 T. Sets the initial value of bundled SBML symbol `C_4_T`."
}
],
"outputs": [
{
"name": "a_1_b",
"maps_to": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.a_1_b",
"description": "A 1 b observable. Maps to SBML symbol `A_1_b`."
},
{
"name": "c_4_t",
"maps_to": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.c_4_t",
"description": "C 4 T observable. Maps to SBML symbol `C_4_T`."
},
{
"name": "state",
"maps_to": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"immunology",
"immunotherapy",
"microenvironment",
"oncology",
"pharmacology",
"physiology",
"sbml",
"systemsbiology",
"tumor-growth"
],
"title": "Ribba2018 - Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy Lab",
"models": [
{
"path": "owned/models/oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model",
"alias": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model",
"provenance": {
"owned_path": "owned/models/oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model_state"
],
"from": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.state"
},
{
"to": [
"visualisation.oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model_summary"
],
"from": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model_species_labels"
],
"from": "oncology_sbml_ribba2018_mathematical_model_of_tumor_uptake_for_model1909050002_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "This is a model developed to predict concentrations of cergutuzumab amunaleukin (CEA-IL2v) after various systemic dosing intensities. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.